Corvetta, Daisy <br/><br/>
Physical interaction between MYCN oncogene and polycomb repressive complex 2 (PRC2) in neuroblastoma: functional and therapeutic implications.  [electronic resource] 

 -  The Journal of biological chemistry  Mar 2013 
 - 8332-8341 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1083-351X 
<br/><br/><label>Standard No.: </label>10.1074/jbc.M113.454280  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>5' Flanking Region<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Base Sequence<br/>Cell Line, Tumor--drug effects<br/>Cell Movement<br/>Cell Proliferation--drug effects<br/>Chromatin--metabolism<br/>Clusterin--genetics<br/>E-Box Elements<br/>Enhancer of Zeste Homolog 2 Protein<br/>Epigenesis, Genetic<br/>Gene Expression Regulation, Neoplastic<br/>Histone Deacetylase Inhibitors--pharmacology<br/>Humans<br/>Hydroxamic Acids--pharmacology<br/>Molecular Sequence Data<br/>N-Myc Proto-Oncogene Protein<br/>Neuroblastoma--drug therapy<br/>Nuclear Proteins--metabolism<br/>Oncogene Proteins--metabolism<br/>Polycomb Repressive Complex 2--metabolism<br/>Promoter Regions, Genetic<br/>Protein Binding<br/>Proto-Oncogene Mas